Ep. 124: Real Income vs. Manufactured Yield — What Actually Funds the Payout

6 curated sources under one throughline (real income vs. manufactured/fragile yield — what funds the payout): NEOS XQQI (~20% distribution from leverage+options, 30-day SEC yield NEGATIVE -0.34% = payout is premium/ROC, not income); a dividend-cut-risk screen (Saratoga/SAR BDC + others without margin to cover payouts); Pfizer 6.4% yield eating FCF ahead of a ~$12B patent cliff; 7 blue-chips at 5yr-high yields (NKE/PEP/MCD/PG/ACN/MKC/LOW) + the payout-ratio test (bargain vs value trap); 2Q26 midstream MLPs (EPD/ET/MPLX/SUN) as REAL FCF-funded 6%+ yield; Morningstar best bond funds 2026 (BND/DODIX, bonds as ballast). Set aside 2 of 8 sent URLs for overlap: the qualityatafairprice substack (Dividend Yield Theory on FDS/SPGI/ICE/MSCI/AON dups the blue-chip yield-percentile method + FDS ran ep123) and the etftrends CPI/VALQ value-ETF piece (thin single-ETF promo, off-throughline).